Articles
Non-Invasive Prenatal Testing Market to Witness Huge Growth by 2024
by VynZ Research Marketing Research ConsultantNon-invasive prenatal testing (NIPT) is a sensitive diagnosis method for identifying specific chromosomal abnormalities in the developing fetus. Chromosomal disorders such as Turner syndrome, Edwards syndrome, Patau syndrome, and down syndrome are some of the diseases which are screened using NIPT.
The global non-invasive prenatal testing market is growing at a significant rate, due to mounting occurrence of chromosomal abnormalities, mounting maternal age and introduction of advanced products.
Request for Sample Copy with depth TOC at https://www.vynzresearch.com/healthcare/non-invasive-prenatal-testing-market/request-sample
On the basis of product, the market is subdivided into instruments and consumables. Repeated supplies of consumables are the factors responsible for the growth of the consumables segment.
On the basis of application, the market is subdivided into microdeletion syndrome, trisomy, and others. Increasing occurrence of chromosomal abnormalities with mounting maternal age is the factor responsible for the growth of the trisomy segment.
The refining reimbursement scenario for NIPT, mounting occurrence of chromosomal abnormalities, Mounting average maternal age, and introduction of advanced products are the primary growth drivers for the non-invasive prenatal testing market.
North America is the largest non-invasive prenatal testing market as in the region the occurrence of chromosomal abnormalities is increasing. Asia-Pacific is observed to witness the fastest growth in the market, due to mounting healthcare expenditure.
Explore Full Research Report Description at https://www.vynzresearch.com/healthcare/non-invasive-prenatal-testing-market
Key players in the non-invasive prenatal testing market are catering to the demand of these devices by investing in technologically advanced products in their product portfolio across the globe.
GE Healthcare, Perkinelmer, Inc., Koninklijke N.V., Qiagen, Pacific Biosciences of California, Inc., Agilent Technologies, Inc., and Beijing Genomics Institute are the key players offering non-invasive prenatal testing.
Source: VynZ Research
Sponsor Ads
About VynZ Research 
Marketing Research Consultant
25 connections, 0 recommendations, 123 honor points.Joined APSense since, August 6th, 2018, From Kolkata, India.
Created on Apr 30th 2019 05:59. Viewed 342 times.
Comments
No comment, be the first to comment.
